Company intelligence / Profile preview

Korion Life Sciences

Ownership: Private
Employees: ~4
Development stage: Other

Overview

Korion Life Sciences is a specialized venture capital fund of funds that provides institutional and individual investors access to top-tier life sciences venture capital opportunities. The firm focuses on investments across biomedical innovation—including biopharma/biotech, medical devices/technology, diagnostics services and digital medicine—primarily at early stages. It does not develop drugs or products itself but enables exposure to diversified clinical pipelines through its underlying VC investments[1][2][4].

Therapeutic areas: OncologyCardiovascularNeurologyOther
Modalities: Small moleculeBiologicMedical deviceDigital health technologies
Industry: Investors

Partnerships

Invests in tier-one US-, Europe-, and Israel-based life sciences VC firms; specific partnerships not disclosed[1]

Beyond the preview

Go deeper on Korion Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Korion Life Sciences.

Explore the full profile